Overdiagnosis of Heparin-Induced Thrombocytopenia in Surgical ICU Patients

被引:43
作者
Berry, Cherisse [1 ]
Tcherniantchouk, Oxana [2 ]
Ley, Eric J. [1 ]
Salim, Ali
Mirocha, James [1 ]
Martin-Stone, Sylvia [3 ]
Stolpner, Dennis [1 ]
Margulies, Daniel R. [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Dept Pharm Serv, Los Angeles, CA 90048 USA
关键词
MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; VENOUS THROMBOEMBOLISM; DIAGNOSIS; PREVENTION; MANAGEMENT; THROMBOSIS; SURGERY;
D O I
10.1016/j.jamcollsurg.2011.04.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Heparin use in surgical patients places them at increased risk for developing heparin-induced thrombocytopenia (HIT). The false positive rate of HIT using the current standard criteria is unknown in surgical ICU patients, who often have confounding factors that cause thrombocytopenia. STUDY DESIGN: Surgical ICU patients, admitted over a 2-year period with a positive screening test for HIT (platelet factor [PF] 4 >= 0.4 optical density [OD]), were reviewed retrospectively at a single institution. Correlation of the Warkentin 4-T score and commercial heparin PF4 ELISA with serotonin releasing assay (SRA) was performed. Logistic regression was used to determine independent risk factors associated with the development of HIT. RESULTS: PF4 tests were requested in 643 patients based on a clinical suspicion of HIT. Of these, 104 patients had a PF4 result, an SRA value (%), and a 4-T score available. Twenty patients (19%) had true positive HIT, defined as a positive PF4 and positive SRA (SRA >= 20%). Eighty-four patients (81%) were false positive, defined as a positive PF4 and negative SRA. Five of 58 patients with Warkentin score of 0 to 3, and 6 of 14 patients with Warkentin score of 6 to 8 were HIT positive by SRA. CONCLUSIONS: In surgical ICU patients, clinical suspicion for HIT necessitates PF4 and SRA analysis. Testing for HIT or treatment with a direct thrombin inhibitor should not depend on the Warkentin 4-T score alone. Although a PF4 >= 0.4 OD is considered a positive screening test for HIT, a PF4 >= 2.0 OD is preferable in surgical ICU patients. (J Am Coll Surg 2011; 213: 10-18. (C) 2011 by the American College of Surgeons)
引用
收藏
页码:10 / 17
页数:8
相关论文
共 27 条
[1]   Prevention of venous thromboembolism in surgical patients [J].
Agnelli, G .
CIRCULATION, 2004, 110 (24) :4-12
[2]  
Ahmad Sarfraz, 2002, Turk J Haematol, V19, P127
[3]   Heparin induced thrombocytopenia: diagnosis and management update [J].
Ahmed, I. ;
Majeed, A. ;
Powell, R. .
POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (983) :575-582
[4]   Heparin-induced thrombocytopenia [J].
Arepally, Gowthami M. ;
Ortel, Thomas L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) :809-817
[5]   Argatroban in the management of heparin-induced thrombocytopenia [J].
Babuin, Luciano ;
Pengo, Vittorio .
VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 :813-819
[6]   Heparin-induced thrombocytopenia in surgical patients [J].
Battistelli, Sandra ;
Genovese, Alberto ;
Gori, Tommaso .
AMERICAN JOURNAL OF SURGERY, 2010, 199 (01) :43-51
[7]   REDUCTION IN FATAL PULMONARY-EMBOLISM AND VENOUS THROMBOSIS BY PERIOPERATIVE ADMINISTRATION OF SUBCUTANEOUS HEPARIN - OVERVIEW OF RESULTS OF RANDOMIZED TRIALS IN GENERAL, ORTHOPEDIC, AND UROLOGIC SURGERY [J].
COLLINS, R ;
SCRIMGEOUR, A ;
YUSUF, S ;
PETO, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1162-1173
[8]   The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients [J].
Crowther, Mark Andrew ;
Cook, Deborah J. ;
Albert, Martin ;
Williamson, David ;
Meade, Maureen ;
Granton, John ;
Skrobik, Yoanna ;
Langevin, Stephan ;
Mehta, Sangeeta ;
Hebert, Paul ;
Guyatt, Gordon H. ;
Geerts, William ;
Rabbat, Christian ;
Douketis, James ;
Zytaruk, Nicole ;
Sheppard, Joanne ;
Greinacher, Andreas ;
Warkentin, Theodore E. .
JOURNAL OF CRITICAL CARE, 2010, 25 (02) :287-293
[9]  
CUKER A, 2009, 2009 CLIN PRACTICE G, P1
[10]   Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia [J].
Dang, CH ;
Durkalski, VL ;
Nappi, JM .
PHARMACOTHERAPY, 2006, 26 (04) :461-468